RNA‐Peptide nanoplexes drug DNA damage pathways in high‐grade serous ovarian tumors

DNA damaging chemotherapy is a cornerstone of current front‐line treatments for advanced ovarian cancer (OC). Despite the fact that a majority of these patients initially respond to therapy, most will relapse with chemo‐resistant disease; therefore, adjuvant treatments that synergize with DNA‐damagi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Bioeng Transl Med
Autors principals: Dreaden, Erik C., Kong, Yi Wen, Quadir, Mohiuddin A., Correa, Santiago, Suárez‐López, Lucia, Barberio, Antonio E., Hwang, Mun Kyung, Shi, Aria C., Oberlton, Benjamin, Gallagher, Paige N., Shopsowitz, Kevin E., Elias, Kevin M., Yaffe, Michael B., Hammond, Paula T.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Research Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5773954/
https://ncbi.nlm.nih.gov/pubmed/29376131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/btm2.10086
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars